Who is sponsoring NCT03746132?

NCT03746132 is sponsored by Neogenix, LLC dba Ogenix.

What condition does NCT03746132 study?

NCT03746132 studies Surgical Wound Healing, Lower Extremity, Revascularization, Incision.

What is the status of NCT03746132?

NCT03746132 is currently UNKNOWN.

Last reviewed 2021-09-09 · How we verify

Oxygen for Vascular Incisional Healing

NCT03746132 NA UNKNOWN

The purpose of this clinical trial is to evaluate Transdermal Continuous Oxygen Therapy (TCOT) as an adjunct to surgical wound healing in subjects undergoing vascular surgery for lower extremity arterial occlusive disease. It is the intention of this study to administer oxygen using the TCOT approach to the surgical sites of subjects undergoing the surgery and to monitor the healing of the incision as well as infection rate. The hypothesis is that oxygen delivered transdermally to the surgical site in a continuous manner for up to 28 days will accelerate the healing process and reduce the infection rate compared to the Standard of Care.

Details

Lead sponsor	Neogenix, LLC dba Ogenix
Phase	NA
Status	UNKNOWN
Enrolment	100
Start date	Thu Mar 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun Jul 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Surgical Wound Healing
Lower Extremity
Revascularization
Incision

Interventions

EPIFLO

Countries

United States